Anti-Inflammatory Activity of Pyrazolo[1,5-a]quinazolines; Molecules; Vol. 29, iss. 11
| Parent link: | Molecules.— .— Basel: MDPI AG Vol. 29, iss. 11.— 2024.— Article number 2421, 24 p. |
|---|---|
| Other Authors: | Crocetti L. Letizia, Khlebnikov A. I. Andrey Ivanovich, Guerrini G. Gabriella, Schepetkin (Shchepyotkin) I. A. Igor Aleksandrovich, Melani F. Fabrizio, Giovannoni M. P. Maria Paola, Quinn M. T. Mark |
| Summary: | Title screen Chronic inflammation contributes to a number of diseases. Therefore, control of the inflammatory response is an important therapeutic goal. To identify novel anti-inflammatory compounds, we synthesized and screened a library of 80 pyrazolo[1,5-a]quinazoline compounds and related derivatives. Screening of these compounds for their ability to inhibit lipopolysaccharide (LPS)-induced nuclear factor κB (NF-κB) transcriptional activity in human THP-1Blue monocytic cells identified 13 compounds with anti-inflammatory activity (IC50 < 50 µM) in a cell-based test system, with two of the most potent being compounds 13i (5-[(4-sulfamoylbenzyl)oxy]pyrazolo[1,5-a]quinazoline-3-carboxamide) and 16 (5-[(4-(methylsulfinyl)benzyloxy]pyrazolo[1,5-a]quinazoline-3-carboxamide). Pharmacophore mapping of potential targets predicted that 13i and 16 may be ligands for three mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase 2 (ERK2), p38α, and c-Jun N-terminal kinase 3 (JNK3). Indeed, molecular modeling supported that these compounds could effectively bind to ERK2, p38α, and JNK3, with the highest complementarity to JNK3. The key residues of JNK3 important for this binding were identified. Moreover, compounds 13i and 16 exhibited micromolar binding affinities for JNK1, JNK2, and JNK3. Thus, our results demonstrate the potential for developing lead anti-inflammatory drugs based on the pyrazolo[1,5-a]quinazoline and related scaffolds that are targeted toward MAPKs Текстовый файл |
| Language: | English |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://doi.org/10.3390/molecules29112421 |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=683079 |
Similar Items
Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Published: (2023)
Published: (2023)
Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25; European Journal of Medicinal Chemistry; Vol. 183
Published: (2019)
Published: (2019)
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia; Pharmaceuticals; Vol. 16, iss. 8
Published: (2023)
Published: (2023)
Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells; European Journal of Pharmacology; Vol. 878
Published: (2020)
Published: (2020)
Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors; Frontiers in Pharmacology; Vol. 13
Published: (2022)
Published: (2022)
c-Jun N-Terminal Kinase (JNK) Inhibitor IQ-1S as a Suppressor of Tumor Spheroid Growth; Molecules; Vol. 30, iss. 21
Published: (2025)
Published: (2025)
Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation; Cells; Vol. 9, iss. 11
Published: (2020)
Published: (2020)
Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats; Molecules; Vol. 24, iss. 9
Published: (2019)
Published: (2019)
Tricyclic Isatin Derivatives as Anti-Inflammatory Compounds with High Kinase Binding Affinity; Molecules; Vol. 30, iss. 14
Published: (2025)
Published: (2025)
Therapeutic Effects of Tryptanthrin and Tryptanthrin-6-Oxime in Models of Rheumatoid Arthritis; Frontiers in Pharmacology; Vol. 11
Published: (2020)
Published: (2020)
Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors; European Journal of Medicinal Chemistry; Vol. 161
Published: (2018)
Published: (2018)
Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11H-Indeno[1,2-b]quinoxalin-11-one Scaffold; Molecules; Vol. 26, iss. 18
Published: (2021)
Published: (2021)
Suppression of Age-Related Macular Degeneration-like Pathology by c-Jun N-Terminal Kinase Inhibitor IQ-1S; Biomedicines; Vol. 11, iss. 2
Published: (2023)
Published: (2023)
c-Jun N-Terminal Kinases and Their Pharmacological Modulation in Ischemic and Reperfusion Brain Injury; Neuroscience and Behavioral Physiology; Vol. 48, iss. 6
Published: (2019)
Published: (2019)
Poly(ε-caprolactone) Scaffolds Doped with c-Jun N-terminal Kinase Inhibitors Modulate Phagocyte Activation; ACS Biomaterials Science and Engineering; Vol. 5, iss. 11
Published: (2019)
Published: (2019)
Electrosprayed poly(lactic-co-glycolic acid) particles as a promising drug delivery system for the novel JNK inhibitor IQ-1; European Polymer Journal; Vol. 127
Published: (2020)
Published: (2020)
Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors; Molecules; Vol. 30, iss. 11
Published: (2025)
Published: (2025)
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury; Frontiers in Pharmacology; Vol. 9
Published: (2018)
Published: (2018)
Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion; Journal of Evolutionary Biochemistry and Physiology; Vol. 59, iss. 3
Published: (2023)
Published: (2023)
Effect of IQ-1 on the Infarct Size and the Parameters of Cardiodynamic Indicators in the Acute Period after Myocardial Ischemia/Reperfusion in Rats; Bulletin of Experimental Biology and Medicine; Vol. 176, iss. 4
Published: (2024)
Published: (2024)
Cardioprotective Effects of a Selective c-Jun N-terminal Kinase Inhibitor in a Rat Model of Myocardial Infarction; Biomedicines; Vol. 11, iss. 3
Published: (2023)
Published: (2023)
Evaluation of Nitric Oxide-Donating Properties of 11H-indeno[1,2-b]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy; Molecules; Vol. 29, iss. 16
Published: (2024)
Published: (2024)
Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential; Biomolecules; Vol. 11, iss. 6
Published: (2021)
Published: (2021)
Neuroprotective Effects of the Lithium Salt of a Novel JNK Inhibitor in an Animal Model of Cerebral Ischemia-Reperfusion; Biomedicines; Vol. 10, iss. 9
Published: (2022)
Published: (2022)
Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity; Molecules; Vol. 27, iss. 12
Published: (2022)
Published: (2022)
Neutrophil Immunomodulatory Activity of Natural Organosulfur Compounds; Molecules; Vol. 24, iss. 9
Published: (2019)
Published: (2019)
Abl silencing inhibits CAS-Mediated process and constriction in resistance arteries; Circulation Research; Vol. 101, iss. 4
Published: (2007)
Published: (2007)
Inhibition of T Cell Receptor Activation by Semi-Synthetic Sesquiterpene Lactone Derivatives and Molecular Modeling of Their Interaction with Glutathione and Tyrosine Kinase ZAP-70; Molecules; Vol. 24, iss. 2
Published: (2019)
Published: (2019)
Synthesis, Antibacterial Properties and Molecular Docking Studies of Nitrogen Substituted 9-(((4X-But-2-ynyloxy)methyl)-1,2,3-triazolyl)–Cinchona Alkaloid Conjugates; Molecules; Vol. 30, iss. 22
Published: (2025)
Published: (2025)
The investigation of structure–activity relationship of polyamine-targeted synthetic compounds from different chemical groups; Amino Acids; Vol. 52
Published: (2020)
Published: (2020)
Antiviral Activity of (1S,9aR)-1-[(1,2,3-Triazol-1-yl)methyl]octahydro-1H-quinolizines from the Alkaloid Lupinine; Molecules; Vol. 29, iss. 23
Published: (2024)
Published: (2024)
Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime; Pharmaceutics; Vol. 15, iss. 7
Published: (2023)
Published: (2023)
Role of protein kinase C, PI3 kinase, tyrosine kinases, NO-synthase, KATP channels and MPT pore in the signaling pathway of the cardioprotective effect of chronic continuous hypoxia; General Physiology and Biophysics; Vol. 37, iss. 5
Published: (2018)
Published: (2018)
6,8-Dibromo-11H-indeno[1,2-b]quinolin-11-one; Molbank; Vol. 2024, iss. 4
Published: (2024)
Published: (2024)
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis; Molecules; Vol. 26, iss. 21
Published: (2021)
Published: (2021)
Chemical Composition and Immunomodulatory Activity of Hypericum perforatum Essential Oils; Biomolecules; Vol. 10, iss. 6
Published: (2020)
Published: (2020)
Neutrophil Immunomodulatory Activity of Farnesene, a Component of Artemisia dracunculus Essential Oils; Pharmaceuticals; Vol. 15, iss. 5
Published: (2022)
Published: (2022)
Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives; Molecules; Vol. 28, iss. 8
Published: (2023)
Published: (2023)
A novel urea derivative anticonvulsant: In vivo biological evaluation, radioreceptor analysis of GABAA receptors and molecular docking studies of enantiomers; Mendeleev Communications; Vol. 33, iss. 4
Published: (2023)
Published: (2023)
Immunotoxicity Study of Cucurbit[n]urils (n = 6, 7, 8) and Modeling of Interaction with Some Monocyte Receptors by a Molecular Docking Method; Molecules; Vol. 30, iss. 10
Published: (2025)
Published: (2025)
Similar Items
-
Novel Tryptanthrin Derivatives with Selectivity as c–Jun N–Terminal Kinase (JNK) 3 Inhibitors; Molecules; Vol. 28, iss. 12
Published: (2023) -
Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25; European Journal of Medicinal Chemistry; Vol. 183
Published: (2019) -
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia; Pharmaceuticals; Vol. 16, iss. 8
Published: (2023) -
Inhibitory effect of IQ-1S, a selective c-Jun N-terminal kinase (JNK) inhibitor, on phenotypical and cytokine-producing characteristics in human macrophages and T-cells; European Journal of Pharmacology; Vol. 878
Published: (2020) -
Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors; Frontiers in Pharmacology; Vol. 13
Published: (2022)